Phillip Pang, Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 5,000 shares at $37.14 ($186K) on 2022-01-05, disclosed to the SEC on 2022-01-06.
Open-market sale of $186k VIR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.14 | 4,600 | $171K | 91.9% |
| 2 | $37.78 | 400 | $15K | 8.1% |
| Total | $37.19 avg | 5,000 | $186K | 100% |
| Filing → |
| VIR | SELL | 2023-06-08 | $130K | — | Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |